We are live on
!
Find out more
ACA
Anchor Capital Advisors Portfolio holdings
AUM
$3.51B
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+16.99%
3 Year Est. Return
+54.72%
5 Year Est. Return
+78.01%
10 Year Est. Return
+273.33%
AUM
$2.75B
AUM Growth
+$25.9M
(+0.95%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
19.62%
Holding
288
New
13
Increased
39
Reduced
163
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$15.8M |
| 2 |
First Hawaiian
FHB
|
+$11.2M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$9.76M |
| 4 |
Booz Allen Hamilton
BAH
|
+$6.34M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$4.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haemonetics
HAE
|
+$29.1M |
| 2 |
Omnicom Group
OMC
|
+$18.7M |
| 3 |
Broadridge
BR
|
+$15.2M |
| 4 |
Sysco
SYY
|
+$13.2M |
| 5 |
APA Corp
APA
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.4% |
| 2 | Healthcare | 15.22% |
| 3 | Technology | 14.09% |
| 4 | Industrials | 9.46% |
| 5 | Consumer Staples | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
1
DELISTED
NuVasive, Inc.
NUVA
| $70.7M | 2.57% |
996,179
+12,202
| +1% | +$776K |
|
2
Conduent
CNDT
$230M
| $60M | 2.18% |
2,662,651
+198,800
| +8% | +$4.08M |
|
3
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $55.1M | 2% |
704,971
-113,461
| -14% | -$8.87M |
|
4
Baxter International
BAX
$11.6B
| $54.7M | 1.99% |
709,551
-78,804
| -10% | -$5.85M |
|
|
5
Broadridge
BR
$17.2B
| $53.6M | 1.95% |
406,318
-119,902
| -23% | -$15.2M |
|
6
Boston Scientific
BSX
$65.8B
| $51.9M | 1.89% |
1,349,244
-33,008
| -2% | -$1.15M |
|
|
STOR
7
DELISTED
STORE Capital Corporation
STOR
| $50.2M | 1.83% |
1,807,463
-25,097
| -1% | -$706K |
|
8
BWX Technologies
BWXT
$16B
| $47.8M | 1.74% |
764,966
-29,977
| -4% | -$1.9M |
|
9
Zimmer Biomet
ZBH
$17.7B
| $47.7M | 1.74% |
373,877
-5,426
| -1% | -$645K |
|
10
Analog Devices
ADI
$181B
| $47.7M | 1.73% |
515,753
-11,282
| -2% | -$1.08M |
|
11
Hasbro
HAS
$12.6B
| $46.9M | 1.71% |
446,269
-4,438
| -1% | -$445K |
|
12
Huntington Bancshares
HBAN
$35.1B
| $46.7M | 1.7% |
3,133,113
-46,133
| -1% | -$721K |
|
13
Sun Communities
SUI
$15B
| $44.5M | 1.62% |
438,467
-2,734
| -0.6% | -$273K |
|
14
M&T Bank
MTB
$36.2B
| $42.1M | 1.53% |
255,764
-1,395
| -0.5% | -$242K |
|
15
Sabra Healthcare REIT
SBRA
$5.64B
| $41.9M | 1.53% |
1,814,131
-38,341
| -2% | -$869K |
|
16
United Bankshares
UBSI
$6.55B
| $39M | 1.42% |
1,074,171
-17,115
| -2% | -$649K |
|
17
First American
FAF
$7.67B
| $38.4M | 1.39% |
743,567
+1,909
| +0.3% | +$104K |
|
|
18
Sysco
SYY
$39.7B
| $37.9M | 1.38% |
516,889
-183,824
| -26% | -$13.2M |
|
|
19
Booz Allen Hamilton
BAH
$8.7B
| $35.9M | 1.3% |
722,654
+129,875
| +22% | +$6.34M |
|
|
PPL
20
PPL Corp
PPL
$27.3B
| $35.6M | 1.29% |
1,216,025
-32,037
| -3% | -$936K |
|
21
Welltower
WELL
$178B
| $34.7M | 1.26% |
539,772
-13,427
| -2% | -$867K |
|
22
Cinemark Holdings
CNK
$3.82B
| $34.6M | 1.26% |
861,248
-6,712
| -0.8% | -$248K |
|
23
Microsoft
MSFT
$2.84T
| $34.4M | 1.25% |
300,554
-9,515
| -3% | -$1.03M |
|
|
STI
24
DELISTED
SunTrust Banks, Inc.
STI
| $34M | 1.24% |
508,547
-1,292
| -0.3% | -$92.2K |
|
25
Dollar General
DG
$25.9B
| $33.8M | 1.23% |
309,413
-5,816
| -2% | -$605K |
|
Similar funds
TH
BCP
TYCC
TCM
DILIC
AAP
KCM
ACM
Anchor Capital Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Anchor Capital Advisors held 288 positions worth $2.75B, up 0.95% from $2.72B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Anchor Capital Advisors withdrew a net $128M in Q3 2018, closing 18 positions and reducing 163 holdings. Its most notable exit was Haemonetics, an estimated $29.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Anchor Capital Advisors opened a new position in Biogen worth $16.3M.
- Anchor Capital Advisors's largest Q3 2018 buy was Biogen: 46,021 shares worth $16.3M.
- Anchor Capital Advisors added most to CDK Global, Inc. in Q3 2018, an estimated $9.76M increase.
- Anchor Capital Advisors's biggest Q3 2018 reduction was Omnicom Group, cutting an estimated $18.7M.
- Anchor Capital Advisors fully exited Haemonetics in Q3 2018, selling an estimated $29.1M.
- Anchor Capital Advisors's ten largest holdings make up 20% of its $2.75B portfolio in Q3 2018.
- Anchor Capital Advisors opened 13 new positions and closed 18 in Q3 2018.
- Anchor Capital Advisors's portfolio value rose 0.95% quarter-over-quarter to $2.75B.
Based on Anchor Capital Advisors's 13F filing for Q3 2018, filed 31 Oct 2018.